Your browser doesn't support javascript.
loading
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer.
Zupancic, Eva; Curato, Caterina; Kim, Jung-Seok; Yeini, Eilam; Porat, Ziv; Viana, Ana S; Globerson-Levin, Anat; Waks, Tova; Eshhar, Zelig; Moreira, João N; Satchi-Fainaro, Ronit; Eisenbach, Lea; Jung, Steffen; Florindo, Helena F.
  • Zupancic E; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Faculty of Medicine (Polo I), Coimbra, Port
  • Curato C; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Kim JS; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Yeini E; Department of Physiology and Pharmacology, Sackler School of Medicine, Room 607, Tel Aviv University, Tel Aviv, Israel.
  • Porat Z; Flow Cytometry unit, Biological Services Department, Weizmann Institute of Science, Rehovot, Israel.
  • Viana AS; Chemistry and Biochemistry Center, Sciences Faculty, Universidade de Lisboa, Lisbon, Portugal.
  • Globerson-Levin A; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Immunology research center, Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Waks T; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Immunology research center, Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Eshhar Z; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Immunology research center, Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Moreira JN; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Faculty of Medicine (Polo I), Coimbra, Portugal; Faculty of Pharmacy (FFUC), University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, Coimbra, Portugal.
  • Satchi-Fainaro R; Department of Physiology and Pharmacology, Sackler School of Medicine, Room 607, Tel Aviv University, Tel Aviv, Israel.
  • Eisenbach L; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Jung S; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Florindo HF; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal. Electronic address: hflorindo@ff.ul.pt.
Nanomedicine ; 14(3): 835-847, 2018 04.
Article en En | MEDLINE | ID: mdl-29306001
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos T Citotóxicos / Linfocitos T CD8-positivos / Vacunas contra el Cáncer / Nanopartículas / Carcinogénesis Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos T Citotóxicos / Linfocitos T CD8-positivos / Vacunas contra el Cáncer / Nanopartículas / Carcinogénesis Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article